Articles about Biotech – Page 2 of 8

Pfizer wins regulatory approval for its $43B acquisition of Seattle-area biotech giant Seagen

Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The… Read More

New website helps engineers find biomedical challenges that crown winning algorithms

There are lots of tasks in biomedicine that are more accurately and efficiently accomplished by a computer than a person… Read More

Washington startups receive $25K grants aimed at boosting state’s life sciences sector

A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel… Read More

Biotech company Absci lays off 30 employees, about 15% of staff

Publicly traded biotech company Absci is laying off 30 employees, or approximately 15% of its workforce.

A-Alpha Bio, a biotech startup that measures and predicts protein interactions, raises $22.4M

Seattle biotech startup A-Alpha Bio raised $22.4 million to boost development of its machine learning platform that analyzes protein-protein interactions.… Read More

Affini-T Therapeutics shutting down Seattle lab

Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Research Center that aims to treat solid tumors, is… Read More

Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal

Swiss biopharma giant Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.2 billion, marking another blockbuster acquisition… Read More

Seattle biotech company is the first to receive approval to test B cell gene therapy in humans

Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the… Read More

Startup funding cooldown: Here are the stats for Seattle and the Pacific NW for the first half of 2022

Tech startups in Seattle and the Pacific Northwest raised less than $4 billion in funding in the first half of… Read More

Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism

Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO… Read More

Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more

Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell… Read More

Vancouver, Wash.-based biotech Absci opens new AI Research Lab in New York City

Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab… Read More

Ex-Athira Pharma CEO Leen Kawas starts $150M fund with key investors from former company

Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered… Read More

New CEO at Zymeworks shifts leadership, plans to lay off 25% of staff

Kenneth Galbraith is shaking up Zymeworks within a week of becoming CEO of the Seattle and Vancouver, B.C.-based biotech company.… Read More

Podcast

Report: Life sciences sector is booming as companies swoop up lab space and raise gobs of cash

It’s hard for life sciences startups to find lab space, and there’s a good reason. The sector has been on… Read More

Chinook Therapeutics helps form China-based biotech venture to treat kidney disease

The news: Chinook Therapeutics on Tuesday announced the formation of SanReno Therapeutics, which will advance therapies for kidney disease in… Read More

Biotech company Absci, which recently went public, cuts ribbon on new HQ in Vancouver, Wash.

Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in… Read More

How pandemic-driven talent migration will change where biotech companies are located

Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria… Read More

Podcast

Biotech boom: How life sciences emerged from ‘the doldrums’ in Seattle and Washington state

Leslie Alexandre has seen a lot from her perch surveying Washington state’s life sciences landscape. She is set to retire… Read More

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for… Read More

These biotech and life sciences CEOs made the leap from software startups — here’s how they did it

In the past several years the barriers between tech and the life sciences have begun to dissolve. AI and machine… Read More

Biotech companies fuel IPO boom in Washington state over the past year

In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped… Read More

New 130K square-foot drug manufacturing plant in Seattle area will develop COVID-19 therapeutics

The Seattle area is home to a new nimble drug manufacturing facility built by Just – Evotec Biologics that was… Read More

Seattle biotech vet Justine Dell’Aringa sees parallels in science while building her own home

At home and at work, Justine Dell’Aringa is up for a challenge. The scientific associate director of Translational Research for… Read More

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a… Read More

Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies

Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More

Immunotherapy startup Umoja lands $210M, less than a year after raising $53M

New funding: Just seven months after announcing a $53 million Series A round, Umoja Biopharma has raised an additional $210… Read More

Oisín raises $5M to develop treatments for ‘zombie cells’ associated with age-related diseases

New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. It’s currently developing preclinical therapies that… Read More

Grandson of Jonas Salk raises cash to find ‘genetic needles in the haystack’

New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based… Read More